Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease

Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease

Introduction: We investigated the effect of intratympanic dexamethasone on control of tinnitus and hearing loss in patients with Meniere’s disease. Materials and Methods: 100 consecutive patients with a diagnosis of Meniere’s disease according to the 1995 criteria of The American Academy of Otolary...

Full description

Bibliographic Details
Main Authors:	Framarz Memari, Fatemeh Hassannia
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2014-07-01
Series:	Iranian Journal of Otorhinolaryngology
Subjects:	Intratympanic dexamethasone Tinnitus Fluctuating hearing loss Meniere’s disease
Online Access:	http://ijorl.mums.ac.ir/pdf_2771_98ff4afe453e9cad231a0f520f58be30.html

Similar Items

Intratympanic injection of dexamethasone for treatment of tinnitus in patients with sudden sensorineural hearing loss
by: Tadao Yoshida, et al.
Published: (2012-01-01)

Effectiveness of intratympanic dexamethasone on tinnitus: a clinical experience
by: İsmail Yılmaz, et al.
Published: (2006-06-01)

Intratympanic corticosteroid perfusion in the therapy of Meniere’s disease
by: Sanković-Babić Snežana, et al.
Published: (2014-01-01)

Effect of Intratympanic Dexamethasone in Idiopathic Sudden Sensorineural Hearing Loss
by: Rabi Hembrom, et al.
Published: (2019-08-01)

Effect of Intratympanic Dexamethasone in Idiopathic Sudden Sensorineural Hearing Loss
by: Rabi Hembrom, et al.
Published: (2019-08-01)

Effectiveness of Intratympanic Dexamethasone Injection for Tinnitus Treatment: A Systematic Review and Meta-Analysis
by: Juyong Chung, et al.
Published: (2022-02-01)

Intratympanic dexamethasone as an adjuvant to oral imipramine hydrochloride (Tofranil, a TCA) 25 mg twice daily in management of idiopathic unilateral subjective tinnitus
by: Tamer A. Abo El Ezz, et al.
Published: (2019-08-01)

Intratympanic treatment for tinnitus: A review
by: Thomas Meyer
Published: (2013-01-01)

Effectiveness of intratympanic injection of dexamethasone in treatment of acute sensorineural hearing loss
by: V. M. Svistushkin, et al.
Published: (2019-04-01)

Vestibular Rehabilitation with Intratympanic Drug Therapy in Meniere's Disease
by: Zeeshan Ayub, et al.
Published: (2022-10-01)

Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss
by: Nezamoddin Berjis, et al.
Published: (2016-01-01)

Combined Intratympanic and Systemic Steroid Therapy for Poor-Prognosis Sudden Sensorineural Hearing Loss
by: Shima Arastou, et al.
Published: (2012-12-01)

Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
by: Sertaç Yetişer
Published: (2018-04-01)

Editorial: Intratympanic and surgical treatment for Meniere's disease
by: Jun Yang, et al.
Published: (2022-12-01)

Quality of life after intratympanic steroid injection for Ménière's disease
by: Annejet A. Schenck, et al.
Published: (2022-06-01)

Association Between the Number of Intratympanic Steroid Injections and Hearing Recovery in Sudden Sensorineural Hearing Loss
by: Yixu Wang, et al.
Published: (2021-12-01)

Controlled release of dexamethasone from fibrin sealant for intratympanic administration in inner ear therapy
by: Jing Zou
Published: (2024-01-01)

Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease
by: Mehrdad Rogha, et al.
Published: (2019-07-01)

Idiopathic sudden sensorineural hearing loss: Effectiveness of salvage treatment with low-dose intratympanic dexamethasone
by: Pedro Salvador, et al.
Published: (2021-01-01)

Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere’s Disease
by: Sasan Dabiri Satri, et al.
Published: (2017-05-01)

Intratympanic Steroids in Severe to Profound Sudden Sensorineural Hearing Loss as Salvage Treatment
by: Jong Dae Lee, et al.
Published: (2010-09-01)

SYSTEMIC CORTICOSTEROIDS ASSOCIATED WITH INTRATYMPANIC CORTICOSTEROID TREATMENT FOR IDIOPATHIC SUDDEN HEARING LOSS
by: Bogdan Cavaleriu, et al.
Published: (2013-07-01)

Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss
by: Mukul Patar, et al.
Published: (2017-08-01)

Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss
by: Mukul Patar, et al.
Published: (2017-08-01)

Combination of Pulse Steroid with Intratympanic Injections in Sudden Sensorineural Hearing Loss
by: Maryam Amizadeh, et al.
Published: (2021-01-01)

Comparison of the Pharmacokinetic Properties of Triamcinolone and Dexamethasone for Local Therapy of the Inner Ear
by: Alec Nicholas Salt, et al.
Published: (2019-07-01)

Idiopathic sudden sensorineural hearing loss: effectiveness of salvage treatment with intratympanic dexamethasone or hyperbaric oxygen therapy in addition to systemic steroids
by: Cinzia Mariani, et al.
Published: (2023-08-01)

A Case of Binocular Vertical Diplopia after Intratympanic Gentamicin Therapy
by: Giacomo Cioffi, et al.
Published: (2019-07-01)

Characteristics of the Cochlear Symptoms and Functions in Meniere′s Disease
by: Yi Zhang, et al.
Published: (2016-01-01)

Comparison of the effect Of three treatment interventions for the control of Meniere’s disease: a randomized control trial
by: Reham Rafei El Shafei, et al.
Published: (2020-09-01)

Primary versus salvage intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss
by: Wei‐Che Lan, et al.
Published: (2023-08-01)

The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere’s Disease
by: Nasrin Yazdani, et al.
Published: (2018-02-01)

Can Intratympanic Steroid Be Initial Therapy for Sudden Sensorineural Hearing Loss?
by: Emre Ocak, et al.
Published: (2014-03-01)

Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss
by: Yu-Jung Hwang, et al.
Published: (2024-01-01)

A study of efficacy of Nigella sativa in treatment of Meniere's disease: A randomized, placebo controlled clinical trial
by: Masoud Motesadi Zarandi, et al.
Published: (2023-04-01)

Intratympanic steroid injection and hyperbaric oxygen therapy for the treatment of refractory sudden hearing loss
by: Filiz Gülüstan, et al.

Safety and Efficacy of Intratympanic Alpha-Lipoic Acid Injection in a Mouse Model of Noise-Induced Hearing Loss
by: Jae Sang Han, et al.
Published: (2022-07-01)

Speech Perception in Ménière Disease
by: Patricia Craveiro Fernandes, et al.
Published: (2023-10-01)

Effects of an Intratympanic Injection of Dexamethasone Combined with Gentamicin on the Expression Level of Serum P0 Protein Antibodies in Patients with Meniere’s Disease
by: Yang Geng, et al.
Published: (2020-11-01)

Association of Sleep Characteristics with Tinnitus and Hearing Loss
by: Matthew Awad, et al.
Published: (2024-01-01)